Shanghai Fosun Pharmaceutical Financials

Market Capitalization CN¥57.29 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	30.53
Forward PE	18.46
Price to Sales TTM	CN¥1.38
Price to Book MRQ	CN¥1.34
Enterprise to Revenue	2.26
Enterprise to EBITDA	17.24

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	5.08%
Operating Margin	8.96%
Return on Assets TTM	1.33%
Return on Equity TTM	4.79%

Income Statement

Revenue TTM	CN¥41,611,309,056
Revenue per Share TTM	CN¥15.47
Quarterly Revenue Growth	12.30%
Gross Profit TTM	CN¥19,784,583,168
EBITDA	CN¥5,901,494,692
Net Income to Common TTM	CN¥2,113,842,304
Diluted EPS TTM	CN¥0.78
Quarterly Earnings Growth YoY	55.40%

Balance Sheet

Total Cash MRQ	CN¥15,630,049,280
Total Cash per Share MRQ	CN¥5.88
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	58.74
Current Ratio MRQ	0.92
Book Value per Share MRQ	CN¥17.78

Cash Flow

Operating Cash Flow TTM	CN¥3,939,213,824
Levered Free Cash Flow TTM	CN¥-520,698,752

600196 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	2,119,389,952
Float Shares	1,680,966,014
Avg 10 Volume	9,947,875
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	42.18%
% Held by Institutions	9.20%

Stock Price Summary

Beta	0.72
Fifty Two Week Low	CN¥20.38
Fifty Two Week High	CN¥30.44
Fifty Two Week Change	3.44%
Day 50 MA	CN¥25.50
Day 200 MA	CN¥24.25

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.08
Forward Annual Dividend Yield	4.54%
Trailing Annual Dividend Rate	CN¥0.27
Trailing Annual Dividend Yield	1.13%
Payout Ratio	34.62%
Dividend Date
Ex Dividend Date	2024-08-06
Last Split Factor
Last Split Date	2010-07-26